Page last updated: 2024-08-16

temozolomide and azd 1480

temozolomide has been researched along with azd 1480 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cartron, PF; Cheray, M; Nadaradjane, A; Pacaud, R; Vallette, FM	1
Ang, BT; Chong, YK; Koh, LWH; Lim, SW; Ng, WH; Sandanaraj, E; Tan, MSY; Tan, NS; Tan, P; Tang, C	1

Other Studies

2 other study(ies) available for temozolomide and azd 1480

Article	Year
Histone H3 phosphorylation in GBM: a new rational to guide the use of kinase inhibitors in anti-GBM therapy. Theranostics, 2015, Volume: 5, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Dacarbazine; Female; Glioblastoma; Histones; Humans; Indoles; Male; Middle Aged; Organophosphates; Phosphorylation; Prognosis; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Pyrazoles; Pyrimidines; Quinazolines; Temozolomide	2015
A STAT3-based gene signature stratifies glioma patients for targeted therapy. Nature communications, 2019, 08-09, Volume: 10, Issue:1 Topics: Animals; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Genetic Predisposition to Disease; Glioblastoma; Humans; Imidazoles; Insulin-Like Growth Factor Binding Protein 2; Mice; Pyrazines; Pyrazoles; Pyrimidines; Receptor, IGF Type 1; STAT3 Transcription Factor; Temozolomide; Xenograft Model Antitumor Assays	2019

Article

Year

Histone H3 phosphorylation in GBM: a new rational to guide the use of kinase inhibitors in anti-GBM therapy.

Theranostics, 2015, Volume: 5, Issue:1

Topics: Adult; Aged; Antineoplastic Agents; Dacarbazine; Female; Glioblastoma; Histones; Humans; Indoles; Male; Middle Aged; Organophosphates; Phosphorylation; Prognosis; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Pyrazoles; Pyrimidines; Quinazolines; Temozolomide

2015

A STAT3-based gene signature stratifies glioma patients for targeted therapy.

Nature communications, 2019, 08-09, Volume: 10, Issue:1

Topics: Animals; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Genetic Predisposition to Disease; Glioblastoma; Humans; Imidazoles; Insulin-Like Growth Factor Binding Protein 2; Mice; Pyrazines; Pyrazoles; Pyrimidines; Receptor, IGF Type 1; STAT3 Transcription Factor; Temozolomide; Xenograft Model Antitumor Assays

2019